Real-life experience with the specific reversal agent idarucizumab for the management of emergency situations in dabigatran-treated patients: a series of 11 cases

When and how to use antidotes for the reversal of direct oral anticoagulants: guidance from the SSC of the ISTH

(2016) J. H. Levy et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Managing reversal of direct oral anticoagulants in emergency situations

(2016) Harry R. Büller et al.   THROMBOSIS AND HAEMOSTASIS

Urgent surgery or procedures in patients taking dabigatran or warfarin: Analysis of perioperative outcomes from the RE-LY trial

(2016) James D. Douketis et al.   THROMBOSIS RESEARCH

Intravenous thrombolysis in acute ischemic stroke after dabigatran reversal with idarucizumab - a case report

(2016) Johannes Sebastian Mutzenbach et al.   Annals of Clinical and Translational Neurology

Novel oral anticoagulants and reversal agents: Considerations for clinical development

(2015) Troy C. Sarich et al.   AMERICAN HEART JOURNAL

Overview of the New Oral Anticoagulants: Opportunities and Challenges

(2015) C. H. Yeh et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Idarucizumab

(2015) John W. Eikelboom et al.   CIRCULATION

Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation

(2015) Hein Heidbuchel et al.   EUROPACE

Non-vitamin K antagonist oral anticoagulants and major bleeding-related fatality in patients with atrial fibrillation and venous thromboembolism: a systematic review and meta-analysis

(2015) Daniel Caldeira et al.   HEART

Idarucizumab for Dabigatran Reversal

(2015) Charles V. Pollack et al.   NEW ENGLAND JOURNAL OF MEDICINE

Design and rationale for RE-VERSE AD: A phase 3 study of idarucizumab, a specific reversal agent for dabigatran

(2015) Paul A. Reilly et al.   THROMBOSIS AND HAEMOSTASIS

The impact of bleeding complications in patients receiving target-specific oral anticoagulants: a systematic review and meta-analysis

(2014) C. Chai-Adisaksopha et al.   BLOOD

Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference

(2013) P. Kirchhof et al.   EUROPACE

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

(2013) Christian T Ruff et al.   LANCET